Functional CD86 (B7-2/B70) on cultured human Langerhans cells

Journal of Investigative Dermatology

Volumn 106, Issue 1, 1996, Pages 147-153

  Yokozeki, Hiroo ^a,c   Katayama, Ichiro ^a   Ohki, Olina ^a   Matsunaga, Tsuyoshi ^a   Watanabe, Ken ^a   Satoh, Takahiro ^a   Azuma, Miyuki ^b   Okumura, Ko ^b   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CK86; T cell activation

Indexed keywords

CD86 ANTIGEN; T6 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LANGERHANS CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030059013     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12329735     Document Type: Article

References (37)

1. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C: B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76-79, 1993
2. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ: Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905-907, 1993
3. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM: Cloning of B7-2: a CTLA-4 counter receptor that costimulates human T cell proliferation. Science 262:909-911, 1993
4. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Hathcock KS, Laszlo G, McKnight AJ, Kim J, Du L, Lombard DB, Gray GS, Nadler LM, Sharpe AH: Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907-909, 1993
5. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191-212, 1993
6. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM: Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 90:11059-11063, 1993
7. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM, Glimcher LH: Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induce B7 expression. Nature 360:266-268, 1992
8. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925-935, 1993
9. Valle A, Aubry JP, Durand I, Banchereau J: IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28; an amplication mechanism for T-B cell interactions. Int Immunol 3:229-235, 1991
10. Linsley PS, Clark EA, Ledbetter JA: The T cell antigen, CD28, mediates adhesion with B cells by interaction with the activation antigen, B7/BB-1. Proc Natl Acad Sci USA 87:5031-5035, 1990
11. Symington FW, Brady W, Linsley PS: Expression and function of B7 on human epidermal Langerhans cells. J Immunol 150:1286-1295, 1993
12. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP: Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell population. J Exp Med 170:1215-1220, 1992
13. + T cells by B7-transfected melanoma cells. Science 259:368-370, 1993
14. Freedman AS, Freeman G, Horowitz JC, Daley J, Nadlere LM: B7, a B cell restricted antigen that identifies preactivated B cells. J Immunol 139:3260-3267, 1987
15. Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL: Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 177:845-850, 1993
16. Yokochi T, Holly RD, Clark EA: B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines and Burkitt's lymphomas. J Immunol 128:823-827, 1982
17. + T lymphocytes by human blood dendritic cells in vitro. J Clin Invest 90:229-237, 1992
18. Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura Ko, Lanier LL, Banchereau J: B70/B7-2 is identical to CD86 and is the major function ligand for CD28 expressed on human dendritic cells. J Exp Med 180:1841-1847, 1994
19. Engel P, Gribben JG, Freeman GJ, Zhou I-J, Nozawa Y, Abe M, Nadler LM, Wakasa H, Tedder TF: The B7-2 (H70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen. Blood 84(5):1402-1407, 1994
20. Gimmi CD, Freeman GJ, Gribben JG, Sugita K, Freedman AS, Morimoto C, Nadler LM: B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interlelikin 2. Proc Natl Acad Sci USA 88:6575-6579, 1991
21. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier IL: CD28 interaction with B7 costimulates primary allogeneic proliferative responses by small, resting T lymphocytes. J Exp Med 175:353-360, 1992
22. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M: CD80 (B7) and CD86 (B 70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154:97-105, 1995
23. Freedman AS, Freeman GJ, Rhynhart K, Nadler LM: Selective induction of B7/BB-1 on interferon-γ-stimulated monocytes: a potential mechanism for amplification of T-cell activation through the CD28 pathway. Cell Immunol 137:429-437, 1991
24. Lenschow DJ, Sperling AI, Cooke MP, Freeman G, Rhee L, Decker DC, Gray G, Nadler LM, Goodnow CC, Bluestone JA: Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol 153:1990-1997, 1994
25. Stack RM, Lenschow DL, Gray GS, Bluestone JA, Fitch FW: IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J Immunol 152:5723-5733, 1994
26. Nickoloff BT, Turka LA: Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 15:464-469, 1994
27. Sontheimer RD: The mixed epidermal cell-lymphocyte reaction II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions. J Invest Dermatol 85:21s-26s, 1985
28. Nickoloff BJ, Mitra RS, Lee K, Turka LA, Green J, Thompson C, Shimizu Y: Discordant expression of CD28 ligans, BB-1 and B7 on keratinocyte in vitro and psoriatic cells in vivo. Am J Pathol 142:1029-1040, 1993
29. Foster CA, Yokozeki H, Rappersberger K, Koning F, Volc-Platzer B, Rieger A, Coligan JE, Wolff K, Stingl G: Human epidermal T cells predominately belong to the lineage expressing α/β T cell receptor. J Exp Med 171:997-1013, 1990
30. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL: Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol 149:1115-1123, 1992
31. Nishioka K, Katayama I, Kobayashi Y: 1a antigen expression by keratinocytes can be the molecules of antigen presentation in contact sensitivity. J Invest Dermatol 88:694-698, 1987
32. Okamoto Y, Shirotori K, Kudo K, Ishikawa K, Ito E, Togawa K, Saito I: Cytokine expression after the topical administration of substance P to human nasal mucosa. J Immunol 151:4391-4398, 1993
33. Liu Y, Linsley PS: Costimulation of T cell growth. Curr Opin Immunol 4:265-270, 1992
34. Girolomoni G, Zambruno G, Manfredini R, Zacchi V, Ferrari S, Cossarizza A, Giannetti A: Expression of B7 costimulatory molecules in cultured human epidermal Langerhans cells is regulated at the mRNA level. J Invest Dermatol 103:54-59, 1994
35. Nozawa Y, Wachi E, Tominaga K, Abe M, Wakase H: A novel monoclonal antibody (FUN-1) identifies an activation antigen in cells of the B-cell lineage and Reed-Sternberg cells. J Pathol 169:309-315, 1993
36. Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, Pearson TC: Regulation of immunostimuratory function and costimulatory molecules (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 152:5208-5219, 1994
37. Simon JC, Dietrich A, Mielke V, Wuttig C, Vanscheidt W, Linsley PS, Schopf E, Sterry W: Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin disease. J Invest Dermatol 103:539-543, 1994